Synergy of lipolysis and lipophagy in alcoholic liver disease

NIH RePORTER · NIH · K99 · $40,986 · view on reporter.nih.gov ↗

Abstract

Project Summary/Abstract The purpose and scope of this supplement is to provide additional funds to mitigate disruptions caused by the COVID19 pandemic on research and training activities related to my parent grant (K99 AA026877). The parent grant seeks to define new mechanisms of lipid catabolism affecting alcoholic liver disease (ALD). The research activities during this period will address Specific Aim 2, which seeks to define a novel, endo-lysosome based mechanism of microlipophagy that is impacted by alcohol consumption. In addition, this supplement will allow me to complete my proposed training in the use of animal models of ALD. The results gained from the proposed research will provide a mechanistic understanding of lipid droplet catabolism in alcoholic fatty liver. Importantly, these studies will provide published research manuscripts and preliminary data in support of a future R01 proposal.

Key facts

NIH application ID
10392064
Project number
3K99AA026877-02S1
Recipient
MAYO CLINIC ROCHESTER
Principal Investigator
Micah Schott
Activity code
K99
Funding institute
NIH
Fiscal year
2021
Award amount
$40,986
Award type
3
Project period
2019-05-20 → 2021-08-31